Psyence Biomedical Ltd.
PBM
$0.73
-$0.03-3.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 269.99% | 736.77% | 736.77% | 736.77% | 219.37% |
| Total Receivables | 39.25% | -- | 229.26% | 229.26% | 565.43% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 65.24% | -- | -21.83% | -21.83% | 907.74% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 59.46% | -- | 21.62% | 21.62% | 0.00% |
| Total Current Assets | 240.09% | -- | 482.26% | 482.26% | 235.34% |
|
|
|||||
| Total Current Assets | 240.09% | -- | 482.26% | 482.26% | 235.34% |
| Net Property, Plant & Equipment | -13.86% | -- | 101.82% | 101.82% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 468.45% | -- | 546.21% | 546.21% | 236.85% |
|
|
|||||
| Total Accounts Payable | -70.72% | -- | -53.43% | -53.43% | -11.91% |
| Total Accrued Expenses | 774.17% | -- | -59.92% | -59.92% | -- |
| Short-term Debt | -- | -- | -- | -- | 76.64% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -56.66% | -- | -70.89% | -70.89% | -- |
| Total Other Current Liabilities | -56.66% | -- | -70.89% | -70.89% | -- |
| Total Current Liabilities | -73.12% | -- | -95.09% | -95.09% | 112.50% |
|
|
|||||
| Total Current Liabilities | -73.12% | -- | -95.09% | -95.09% | 112.50% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 76.64% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -73.12% | -- | -95.09% | -95.09% | 112.50% |
|
|
|||||
| Common Stock & APIC | 30.12% | -- | 33.88% | 33.88% | 5,490.56% |
| Retained Earnings | -7.23% | -- | 1.76% | 1.76% | -- |
| Treasury Stock & Other | 370.21% | -- | 292.38% | 292.38% | -- |
| Total Common Equity | 1,045.51% | 161.26% | 161.26% | 161.26% | -27.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1,045.51% | 161.26% | 161.26% | 161.26% | -27.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,045.51% | 161.26% | 161.26% | 161.26% | -27.80% |
|
|
|||||